Pharmacodynamics of co-administration of uracil and 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) for malignant brain tumors.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000378:metabolism*; D000971:Antineoplastic Combined Chemotherapy Protocols; D001921:Brain / Q000378:metabolism; D001932:Brain Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D004338:Drug Combinations / Q000378:metabolism; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D005641:Tegafur / Q000378:metabolism; D014498:Uracil / Q000378:metabolism
D000970:Antineoplastic Agents; D004338:Drug Combinations; D005641:Tegafur; D014498:Uracil